Company News
- CTD Holdings Files Clinical Trial Application with Italian Drug Agency to Continue Advancing Trappsol(R) Cyclo(TM) Drug Development Program to Treat Niemann-Pick Disease Type C
Dec 21, 2016, 8:00 AM EST - CTD Holdings to Present at the WORLDSymposium on Compassionate Use of Cyclodextrins to Treat Niemann Pick Disease Type C and on Progress in US and EU Clinical Trials
Dec 15, 2016, 12:09 PM EST - CTD Holdings to Present at the 2016 BioFlorida Annual Conference on Use of Cyclodextrins to Treat Niemann Pick Disease Type C
Dec 8, 2016, 8:00 AM EST - CTD Holdings Announces Approval of Clinical Trial Application to Conduct Phase I/II Clinical Study of Trappsol(R) Cyclo(TM) in Patients with Niemann-Pick Type C Disease at Karolinska University Hospital
Nov 10, 2016, 8:00 AM EST - CTD Holdings Presents on Clinical Trials at Niemann-Pick UK Conferences
Sep 28, 2016, 7:00 AM EDT - CTD Holdings Announces MHRA Approval of Clinical Trial Application for Treatment of NPC With Trappsol(R) Cyclo(TM)
Sep 15, 2016, 7:00 AM EDT - CTD Holdings Files Clinical Trial Application With Swedish Medical Products Agency to Continue Advancing Its Drug Development Program
Sep 12, 2016, 7:00 AM EDT - CTD Holdings Announces FDA Acceptance of Investigational New Drug Application for Treatment of NPC With Trappsol(R) Cyclo(TM)
Sep 6, 2016, 7:00 AM EDT - CTD Holdings Meets With Parent Advocate Groups and Physicians
Aug 16, 2016, 11:14 AM EDT - CTD Holdings Files Investigational New Drug Application With US FDA to Further Advance Its Drug Development Program
Aug 8, 2016, 7:00 AM EDT
